AVELUMAB
avelumab 200 mg/10 mL injection, 10 mL vial
AVELUMAB (13122P)
13122P
Manner of administration:Injection
Restriction 15485
Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 800 mg | # of repeats: 7 | DPMA: $5,249.19 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
